MTOR and cancer: Our data indicate that when mTOR signaling is activated in cancer cells within the TME, endothelial proliferation activity increases, driven by the upregulation of pro‐angiogenic factors such as vascular endothelial growth factor (VEGF) and IL‐8.[16]